Obesity Treatment Market Size to Reach USD 27.10 Billion in 2028

Rise in government initiatives to address overweight issues and increasing development of advanced and effective weight management treatments are among the key factors contributing to market growth

Market Size – USD 8.36 Billion in 2020, Market Growth - CAGR of 16.7%, Market Trends – Technological advancements in healthcare

The global obesity treatment market size is expected to reach USD 27.10 billion by 2028 at a CAGR of 16.7%, according to a new report by Reports and Data. One of the key parameters driving market revenue growth is rising prevalence of obesity due to sedentary lifestyles, unhealthy eating habits, and lack of physical activity. The global market growth is further bolstered by increasing commercial availability of weight-management programs, rising demand for technologically enhanced weight-loss devices and equipment, and rise in government initiatives undertaken to promote awareness about obesity and its adverse health outcomes. Furthermore, growing trends of health and fitness such as gym culture, increasing cosmetic concerns, especially among millennials, increasing inclination towards weight-loss surgeries, and rising healthcare expenditure create market growth opportunities.

Obesity is a medical condition caused by growing size of fat cells in the body. This condition is associated with various health problems including diabetes, cardiovascular disease, high blood pressure and several types of cancer. Some of the major causes of obesity include lack of sleep, physical inactiveness, and excessive consumption of junk food. It is considered that the mainstay of obesity treatment is changes in lifestyle such as adequate diet and physical fitness. Dietary changes, improved physical activity, and behavioral changes are proven to help improve the condition and prevent various obesity-related health issues. In more serious cases, specific weight-loss procedures and medications are prescribed by physicians. Some commonly known FDA-approved weight-loss drugs are orlistat (Xenical, Alli), naltrexone-bupropion (Contrave), phentermine-topiramate (Qsymia), semaglutide (Wegovy), and liraglutide (Saxenda).

Access Free sample PDF Copy of the Report @ https://www.reportsanddata.com/sample-enquiry-form/1480

Some Key Highlights in the Report:

  • Based on surgery type, the Biliopancreatic Diversion with Duodenal Switch (BPD/DS) segment is the leading segment, with the highest revenue share in the global obesity treatment market in 2020. Increasing prevalence of obesity-related health issues such as high blood pressure, type 2 diabetes, and other medical problems and growing preference for surgical procedures are expected to bolster this segment’s growth in the coming years.
  • Based on drug type, the combination drugs segment reached the largest market share in 2020. Surging prevalence of obesity worldwide and introduction of effective combination therapies for weight management fuel this segment’s growth.
  • North America accounted for the largest revenue share of 53% in the global obesity treatment market in 2020. Easy availability of minimally invasive procedures, increasing investments in technological innovations, and rise in research & development activities are the key factors driving the North America market growth. The Asia Pacific market is expected to register the highest CAGR of 18% during the forecast period. Growing awareness about the unfavorable health impacts of obesity, advancing healthcare infrastructure, and growing medical tourism are projected to boost market growth in this region.
  • The leading players in the global obesity treatment market include Medtronic, Ethicon (subsidiary of Johnson & Johnson), Cousin Biotech, EnteroMedics, Inc., and USGI Medical, Inc. VIVUS, Inc., Arena Pharmaceuticals, Inc., F. Hoffmann-La Roche Ltd., Novo Nordisk A/S, and Allergan Plc.

Request for Custom Research @ https://www.reportsanddata.com/request-customization-form/1480

For the purpose of this report, the global obesity treatment market is segmented on the basis of surgery type, medication type, end-use, and region:

Surgery Type Outlook (Revenue, USD Billion; 2018-2028)

  • Biliopancreatic diversion with Duodenal Switch (BPD/DS)
  • Adjusting gastric Banding
  • Roux-en-Y Gastric Bypass
  • Sleeve gastrectomy
  • Endoscopic Procedures

Drug Type Outlook (Revenue, USD Billion; 2018-2028)

  • Appetite suppressants
  • Combination drugs
  • Malabsorption
  • Satiety drugs

End-use (Revenue, USD Billion; 2018-2028)

  • Clinics
  • Hospitals
  • Beauty institutions
  • Others

Buy now your Exclusive copy of Report @ https://www.reportsanddata.com/checkout-form/1480

Regional Outlook (Revenue, USD Billion; 2018-2028)

  • North America
    • U.S.
    • Canada
  • Europe
    • Germany
    • U.K.
    • France
    • Rest of Europe
  • Asia Pacific
    • China
    • Japan
    • India
    • South Korea
    • Rest of the Asia Pacific
  • Latin America
    • Brazil
    • Rest of Latin America
  • Middle East & Africa
    • Saudi Arabia
    • UAE
    • Rest of the Middle East & Africa

Explore Reports and Data's Prime Analysis of the global Healthcare & Pharmaceutical Industry:

Cerebral Thrombectomy Systems Market Size, Share & Analysis, By Type (Suction Devices, Catheters with Balloons, Snares, Enveloping Coils, Rheolytic Devices, Laser-Based Devices), By Utility (Reusable Devices, Disposable Devices), By End-User (Hospitals, Academic Research Centers, Others), And By Region, Forecast To 2027        

Clinical Trial Management System (CTMS) Market Size, Share & Analysis, By Delivery Mode (Web-based CTMS, Licensed Enterprise CTMS, Cloud-based CTMS), By End-User (Pharmaceutical & Biopharmaceutical Companies, Contract Research Organizations, Medical Device Companies, Hospitals, Academic Research Centers), And By Region, Forecast To 2027

Big Data Analytics in Healthcare Market Size Share & Trends Analysis Report by By Component (Software, Services), by Deployment (On-Premise, Cloud), by Analytics Type, by Applications, By End User, by Region, Competitive Strategies and Segment Forecasts, 2016 – 2026

About Reports and Data

Reports and Data is a market research and consulting company that provides syndicated research reports, customized research reports, and consulting services. Our solutions purely focus on your purpose to locate, target and analyze consumer behavior shifts across demographics, across industries and help client’s make a smarter business decision. We offer market intelligence studies ensuring relevant and fact-based research across a multiple industries including Healthcare, Technology, Chemicals, Power and Energy. We consistently update our research offerings to ensure our clients are aware about the latest trends existent in the market. Reports and Data has a strong base of experienced analysts from varied areas of expertise.

Contact Us:

John W

Head of Business Development

Reports and Data | Web: www.reportsanddata.com

Direct Line: +1-212-710-1370

E-mail: sales@reportsanddata.com

Read Full Press Release: https://www.reportsanddata.com/press-release/global-obesity-treatment-market

Back to news